Weight gain in men tied to higher risk of fatal prostate cancer Dr. Kamal Kant Kohli20 Jun 2023 8:00 PM ISTSweden: Data analysis on more than 250,000 men in Sweden found that weight gain over the course of a man's life was associated with developing...
Integrated pathway to detect prostate cancer early obviate need for biopsy Aditi6 Jun 2023 8:00 PM ISTA research article published in EUROPEAN UROLOGY ONCOLOGY validated a pathway that finds MRI biomarkers and microRNAs as triage tests for the early...
USFDA nod to AstraZeneca, MSD's Lynparza plus Abiraterone and Prednisone or Prednisolone for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer Ruchika Sharma2 Jun 2023 3:30 PM ISTRahway: AstraZeneca and Merck, known as MSD outside of the United States and Canada, has announced that LYNPARZA in combination with abiraterone...
Medical Bulletin 12/May/2023 Isra Zaman12 May 2023 4:45 PM ISTHere are the top medical news for the day:Online gaming social networks may have a positive impact on mental health: StudyA new study published in...
Bone biomarkers and prostate cancer survival strongly linked: Study Isra Zaman12 May 2023 9:15 AM ISTProstate cancer falls the top ten leading sites of occurrence for cancer in India. Understanding the factors that influence patient outcomes is...
Medical Bulletin 2/May/2023 Isra Zaman2 May 2023 4:20 PM ISTHere are the top medical news for the day:Heart damage cause from cancer drugs identifiedSafer cancer drugs are now one step closer after a new study...
Pfizer, Astellas Pharma' Xtandi combo therapy cuts risk of metastasis, death by 58 percent in prostate cancer Ruchika Sharma2 May 2023 12:30 PM ISTXTANDI (enzalutamide) is an androgen receptor signaling inhibitor.
Transgender women may also be at risk for prostate cancer: JAMA Dr. Kamal Kant Kohli2 May 2023 9:45 AM ISTResearchers have found in a new study that Transgender women may also be at risk for prostate cancer.Transgender women keep their prostates even after...
Prostate cancer risk for transgender women Isra Zaman2 May 2023 9:30 AM ISTTransgender women keep their prostates even after gender-affirming surgery, but the extent to which they remain at risk of prostate cancer has been...
USFDA panel backs restricted use of AstraZeneca Prostrate cancer drug Ruchika Sharma29 April 2023 12:30 PM ISTLynparza belongs to a class of drugs called PARP inhibitors, which include Clovis Oncology's Rubraca and GSK Plc's Zejula.
5 alfa-reductase inhibitors not significantly associated with prostate cancer mortality: JAMA Jacinthlyn Sylvia25 April 2023 8:00 PM ISTThere was no statistically significant correlation between the use of 5 alfa-reductase inhibitor (5-ARI) and prostate cancer (PCa) mortality in a...
Novartis lifts full year earnings on higher prescriptions Ruchika Sharma25 April 2023 11:37 AM ISTFirst-quarter group sales gained 3 percent to $12.95 billion, above an analyst consensus of $12.55 billion, driven by better than expected revenues...
